Tortugas Neuroscience

Tortugas Neuroscience was founded in 2021, is headquartered in Framingham, United States, lists 1–10 employees, and has $106.0M in recorded funding across 1 round.

Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$106.0M
Last Round
$106.0M Series AApr 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

Tortugas Neuroscience is a neurology-focused biotech company dedicated to developing novel medicines with derisked mechanisms of action for large, well-defined central nervous system indications. Launched in April 2026 with $106 million in Seed and Series A financing, the company is led by biotech veterans Jeff Jonas, M.D. (CEO) and Al Robichaud, Ph.D. (President, Head of R&D), both formerly of Sage Therapeutics. Its clinical-stage pipeline includes in-licensed programs from Eisai and Jiangsu Hansoh Pharmaceutical targeting schizophrenia, tinnitus, focal epilepsy, and reversible encephalopathies, with a strategic focus on once-daily oral formulations and clear regulatory pathways to approval.

Summary

Tortugas Neuroscience is a Biotech company based in Framingham, United States, founded in 2021. It lists 1–10 employees. It has raised $106.0M in total across 1 round, most recently a $106.0M Series A round in Apr 2026. Investors include The Column Group, Cure Ventures and AN Venture Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2026
$106.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tortugas Neuroscience on Indexed.vc
<a href="https://indexed.vc/companies/tortugas-neuroscience"><img src="https://indexed.vc/api/badge/company/tortugas-neuroscience" alt="Tortugas Neuroscience on Indexed.vc" width="260" height="76" /></a>